The essence of this project is to establish a collaborative training network which will develop novel immune-regulatory molecules from Bifidobacterium infantis 35624, for treatment of inflammatory diseases.

A multidisciplinary team of five European partners are collaborating on this project:

  • Swiss Institute for Asthma and Allergy Research
    (Coordinator and expert in immune-regulation);

    University College Cork, Alimentary Pharmabiotics Centre and Department of Microbiology (expert in bioinformatics and glycobiology assembly in probiotic bacteria);

  • Vienna Institute of Biotechnology at Universität für Bodenkultur (expert in glycobiology);

  • Alimentary Health Ltd (expert in developing probiotic products);

  • Alimentary Health Pharma Davos AG (expert in microbial biochemistry and pharmaceutical development).







Funded by the European Union Seventh Framework Programme.

Marie Curie Industry-Academia Partnerships and Pathways.

Copyright © 2014. TEAM-EPIC. All Rights Reserved.